# CKD-828 Drug Interaction Study (Telmisartan)

> **NCT01356017** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Telmisartan 80mg, S-amlodipine 5mg
- **DRUG:** Telmisartan 80mg

## Key facts

- **NCT ID:** NCT01356017
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2011-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356017, "CKD-828 Drug Interaction Study (Telmisartan)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01356017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*